Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation.

Carolina MalageladaAdoración NietoSara MendezAnna AccarinoJavier SantosJuan-R MalageladaFernando Azpiroz

Published in: Journal of gastroenterology and hepatology (2017)

Prucalopride reduces abdominal symptoms without modifying gas retention when patients with functional bowel disorders are challenged with the gas transit and tolerance test. European Clinical Trials Database (EudraCT2011-006354-86).

Keyphrases

room temperature
clinical trial
carbon dioxide
emergency department
depressive symptoms
randomized controlled trial
adverse drug
irritable bowel syndrome
phase ii
ionic liquid
study protocol